drugset / Trial / NCT07612631

Imaging CRF X NOP Interactions in Alcohol Use Disorder

NCT07612631

NaSingle-groupOpen-labelBasic science

Summary

This positron emission tomography imaging study uses \[C-11\]NOP-1A and hydrocortisone to image stress-modulating proteins in heavy drinking alcohol use disorder (AUD) subjects and healthy controls (HC). It will also characterize the role of these stress-regulating proteins in a relapse to alcohol.

Timeline

Start
2026-06-01
Primary completion
2031-06-30
Completion
2032-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrocortisone Other / unclassified 1 mg/kg Intravenous